Uppsala university department of surgical sciences
Uppsala, 75310, Sweden
NCT Number: NCT06234709
This is a register-based study
The aim of this study is to investigate how common comorbidity is in different age groups and which comorbidity that has the greatest impact on mortality considering different admission diagnosis and after the acute phase compared to the general population. Also, how different degrees of comorbidity affect mortality, adjusted for other comorbidities and SAPS 3?
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Uppsala, 75310, Sweden
The study population included all patients > 16 years old admitted to an ICU during the years 2006 to 2012 and registered in the Swedish Intensive Care Registry (SIR).
Hospital discharge diagnoses from in-patient care five years preceding the index time for the ICU admission were extracted from the National Patient Register (NPR) and linked to ICU admissions using unique person identity numbers. Follow-up for all-cause mortality were extracted from the cause of death register at NPR.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The study population included all patients > 16 years old admitted to an ICU during the years 2006 to 2012 and registered in the Swedish Intensive Care Registry (SIR)
Exclusion criteria
-
Time frame: january 1, 2005 til december 31, 2016
Extracted from the cause of death register at National Patient Registry in Sweden.
Anna Aronsson
Other
Comorbidity With Greatest Impact on Mortality Considering Different Admission Diagnosis and After Landmark Time in an Intensive Care Population Compared to the General Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03628300
Acute Kidney Injury, Beta Lactams
Amiens, France
View Trial DetailsNCT05960994
Critical Care, Intensive Care Units
São Paulo, Brazil
View Trial DetailsNCT05937646
Behavior, Communication
Chapel Hill, North Carolina, United States
View Trial DetailsNCT03683329
Cancer, Critical Care
Marseille, France
View Trial Details